Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Learn what's the best investment strategy to help you maximize your returns and achieve your financial goals.
22,631 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
New surveys reveal a sharp contrast: americans trust financial advice from employers, yet a growing share doubt they’...
Rigetti Computing stunned markets with a blistering rally, but behind the numbers lies a complicated story. This piec...
Accenture has ordered associate directors and senior managers to demonstrate regular AI tool usage to be considered f...
Tragedy tests more than emotions — it tests finances too. This article crafts a practical plan to build resilience af...
When a high-quality dividend stock dives by more than a third, smart investors look beyond the fall. This guide break...
AI data centers are expanding rapidly, yet a constrained pool of electricians threatens timelines. Gen Z is increasin...
JPMorgan Chase CEO Jamie Dimon cautions that inflation could reappear if geopolitical shocks linger, rattling investo...
A new nationwide survey finds some households earning more than $300,000 a year report paycheck-to-paycheck constrain...
You don't need to chase risky bets to beat the market. With $3,000, you can target the smartest growth stock with dur...
Intuit has faced a sharp share-price pullback this year. This guide breaks down the why, the risk factors, and what i...
A year of dramatic moves has put Dave (DAVE) on investors' radar. A newly disclosed $7 million stake from a prominent...